Lecture 7: Asthma Flashcards

1
Q

What is the WHO definition of asthma?

A

Is a disease characterized by recurrent attacks of breathlessness and wheezing, which vary in severity and frequency from person to person. In an individual, they may occur from hour to hour and day to day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When does asthma most commonly present?

A

In childhood or in middle age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What % of children with mild asthma will be symptom free by 21yo?

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What % of people with more persistent asthma will continue to have symptoms into adulthood?

A

70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What causes airflow obstruction in asthma?

A

Bronchoconstriction - contraction of the smooth muscle in the bronchial wall

Bronchial secretions and plugs of mucus - due to inflammation of the bronchial wall

Oedema of the bronchial wall - due to inflammation the lining mucosa of the bronchial wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is atopy?

A

Asthma in young people usually linked to atopy

Tendency to form IgE antibodies to allergens (such as pollen, house dust mites or animals)

Often associated hay fever or eczema in the personal or family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which interleukins are associated with B cell and plasma cell activation?

A

IL-4 and IL-13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What receptor is expressed by bast cells and basophils that are activated in asthma?

A

FCeRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What interleukin is associated with activation of eosinophils?

A

IL-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is released in response to mast cell, basophil and eosinophil activation in asthma?

A

Histamine
Leukotrienes
Prostaglandins
Cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the symptoms of asthma?

A

Cough
Wheeze
Breathlessness
Chest tightness

Occurs in episodes with periods of no (or minimal symptoms)

Diurnal variability-so worse at night or early morning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What mechanisms can act as triggers in asthma?

A

Aspirin
Ibuprofen
Beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What must be taken into account when diagnosing asthma?

A

History is crucial-need more than one symptom

Symptom free periods

Past medical history (previous wheezing illness, hay fever, eczema), family history (of any atopic disease), and social history (occupation, pets) can provide clues

Alternative diagnosis unlikely-what could these be?

Physical examination may be normal except during an attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What investigations can be carried out to assess asthma?

A

GP:

  • peak flow monitoring-twice day for 2 weeks
  • spirometry may show airflow obstruction, but may be normal between attacks

GP/Hospital:

  • chest X-ray often normal, but may show hyperinflation
  • increased eosinophil count in the blood
  • fraction exhaled nitric oxide (FeNO)

Hospital:
- skin prick or blood tests may confirm allergies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do you know if theres airflow obstruction?

A

FEV1/FVC ratio <70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What peak flow would be expected in asthma?

A

20% diurnal variation

Worse at night/early morning

17
Q

Is the affect on lung function reversible?

A

With bronchodilators (so after treatment with salbutamol) 15% and 200mls improvement in FEV1 from baseline

18
Q

What is FeNO?

A

Fraction of exhaled nitric oxide

Measure of airways eosinophilic inflammation

Performed on patients not on any treatment

A positive test (> 40ppb) supports diagnosis of asthma

Can be used to monitor treatment/look at compliance

19
Q

What are the non-pharmacological management options for asthma?

A

Smoking cessation

Weight reduction

Pollution-may provoke acute asthma or aggravate existing asthma but effects from allergens, smoking and infection more significant

20
Q

What are the pharmacological management options for asthma?

A

“Preventers”

  • Inhaled corticosteroids (ICS)
  • Inhaled Long acting beta 2 agonists (LABA)
  • Leukotriene or theophylline when poorly controlled

“Relievers”
- Short acting beta agonists (SABA)

21
Q

What is the first line treatment in patients with asthma?

A

Inhaled corticosteroids (ICS)

Beclometasone, fluticasone, budesonide, ciclesonide

22
Q

When should LABAs be used in asthma?

A

Formoterol Salmeterol

In combination with ICS as add on treatment if still symptomatic

Never a single agent treatment alone: associated with increased deaths

23
Q

What SABA are used?

A

Salbutamol/Terbutaline - As inhaler (100mcg) or nebuliser (high dose 2.5mg, driven by oxygen)

24
Q

What is MART?

A

LABA formoterol has short onset of action - equivalent of salbutamol (SABA)

So certain specific ICS/LABA combinations can be used as relievers as well as preventers

So patients can take additional doses (4/day) for short period (2-3 days) to rapidly treat any worsening asthma symptoms

25
Q

What are dry powder inhalers?

A

Activated by inspiration by the patient

Powdered drug is dispersed into particles by the inspiration

26
Q

What are pressurised metered dose inhalers?

A

Drug dissolved in a propellant hydrofluorocarbons (HFCs) under pressure valve system releases a metered dose

27
Q

What are the proportions of patients making no mistakes with their inhalers (DPI, pMDI and pMDI+spacer)?

A

DPI - 53-59%

pMDI - 23-43%

pMDI+spacer - 55-57%

28
Q

What should be considered before deciding which inhaler to prescribe?

A

Where are they in treatment

What device can they use

Dexterity

Inspiratory flow

Side effects: oral candidiasis/thrush (ICS), tremor + tachycardia (SABA/LABA)

What device do they want to use (HFCs)

Carbon footprint

Cost

29
Q

What are the three key questions in asthma?

A

Have you had difficulty sleeping because of your asthma symptoms (including cough)?

Have you had your usual asthma symptoms during the day (cough, wheeze, chest tightness or breathlessness)?

Has your asthma interfered with your usual activities (eg housework, work, school)?

30
Q

What are the specialised treatments available in asthma?

A

Monoclonal antibody

  • anti-IgE injections (omalizumab)
  • anti IL-5 treatment (mepolizumab)
31
Q

What are the reasons for low compliance with inhalers?

A

Unintentional

  • Misunderstanding
  • Poor inhaler technique
  • Language
  • Forgetfulness, stress

Intentional

  • Concern about side-effects
  • Denial
32
Q

What are the benefits to a PAAP?

A

Improves asthma control

Reduces emergency contacts with GP

Reduces hospital admissions

33
Q

What are the features of acute sever asthma?

A

Peak expiratory flow rate (PEFR)- 33-50% of best

Can’t complete sentences in one breath

Respirations ≥25 breaths/min

Pulse ≥110 beats/min

34
Q

What are the features of life threatening asthma?

A

PEFR <33% of best or predicted

SpO2 <92%ƒ

Silent chest, cyanosis, or feeble respiratory effort

Arrhythmia or hypotension

Exhaustion, altered consciousness

35
Q

When can someone be discharged from hospital?

A

Been on discharge medication for 24 hours

Inhaler technique checked and recorded

PEFR >75% of best or predicted and PEFR diurnal variability<25%

Treatment with oral and inhaled steroids in addition to bronchodilators

Own PEFR meter and written PAAP

GP/Nurse follow up arranged within 2 working days

Follow up appointment in respiratory clinic within 4 weeks